Centre rejects reports of dissent by experts about increasing gap between Covishield doses
First Published: 16th June, 2021 18:45 IST
The Union Health Ministry on Wednesday dismissed media reports claiming there was dissent from technical experts about increasing the gap between two Covishield doses and said the decision was based
The Union Health Ministry on Wednesday dismissed media reports claiming there was dissent from technical experts about increasing the gap between two Covishield doses and said the decision was based on scientific reason about the behaviour of adenovector vaccines.
The Centre on May 13 had approved extending the gap between the two doses of the Covishield vaccine from six to eight weeks to 12 to 16 weeks following a recommendation from the National Technical Advisory Group on Immunisation (NTAGI).
The 22nd meeting of COVID-19 Working Group of NTAGI was held on May 10. There, a proposal for a change in dose interval for Covishield, used under the National Vaccination Policy, was considered.
Based on the real-life evidences, particularly from the United Kingdom, the COVID-19 Working Group agreed to increase the interval between two doses of Covishield Vaccine to 12 to 16 weeks, the Health Ministry said in a statement.
This recommendation was taken up for discussion at the meeting of the Standing Technical Sub-Committee (STSC) of NTAGI held on May 13 under the joint chairpersonship of the secretary of the Department of Biotechnology, the secretary of Department of Health Resources and the DG of the Indian Council of Medical Research, it said.
“The STSC of NTAGI gave the following recommendation: ”as per the COVID-19 Working Group recommendation, a dosing interval of minimum three months between two doses of Covishield vaccine was recommended”,” the statement said.
“It may be noted that the decision of increasing the gap is based on scientific reason regarding behaviour of adenovector vaccines and has been discussed thoroughly in meetings of COVID-19 Working Group and STSC of NTAGI with no dissent from any member,” it said.
In both the meetings — of the COVID-19 Working Group and of the STSC — no dissent was given by any of the three members who have been quoted in the news report, namely Dr Mathew Varghese, Dr M D Gupte and Dr J P Muliyil, the statement said.
It also said that Dr Varghese has denied talking to the reporter on the issue of his alleged dissent. PTI
COMMENTS
TOPMOST STORY NOW
Live Agartala-Guwahati bus accident in Assam: 1 dead, several injured
02nd May 2024Live Meghalaya: Umiam bridge repair works to be completed on time, informs CM Conrad Sangma
02nd May 2024Live Lok Sabha Polls- Assam: BPF chief Hagrama Mohilary believes his run of good luck will continue
02nd May 2024Live Suspense continues over Rahul, Priyanka’s candidatures from Raebareli and Amethi; final decision today
02nd May 2024WE RECOMMEND
Suspense continues over Rahul, Priyanka’s candidatures from Raebareli and Amethi; final decision today
The sources added that along with Congress leaders, its partners in the INDIA bloc also suggested that Rahul contest Amethi.
02nd May 2024Close to 100 schools in Delhi-NCR get bomb threat mails. Who sent the mails? What is the truth?
According to Delhi Police, the bomb threats sent via email to schools originated from Russia, as indicated by the IP address of the email, which was traced back to the domain "mail.ru"
01st May 2024Multiple schools across Delhi-NCR receive bomb threat, students evacuated; Delhi Police begin probe
Bomb detection teams, bomb disposal squads and officials of Delhi Fire Service have been rushed to schools and search operations are underway, a police officer said.
01st May 2024Delhi HC directs government to frame policy for compensating deaths due to Chinese ‘manjha’
In 2017, the Chinese Manjha was banned by the Indian government.
01st May 2024Licence of 14 Patanjali products cancelled. Check details here
In an affidavit filed in the Supreme Court, the licencing body said that it had suspended licenses of 14 products manufactured by Patanjali's Divya Pharmacy in connection with the misleading advertisements case.
30th April 2024